Favrille Finds $44M

San Diego-based Favrille has landed $44M in a Series C financing. The round was led by William Blair Capital Partners, and included new investors Needham Capital Partners, Avtech Ventures, Oakwood Medical Investors, and others. Current investors also participated. The company is developing drug therapies for cancer and autoimmune diseases. More information »